US 12,459,953 B2
TREM2 modulators
Jakob Busch-Petersen, Frederiksberg (DK); and Gavin Whitlock, Sandwich (GB)
Assigned to Muna Therapeutics ApS, Frederiksberg (DK)
Filed by Muna Therapeutics ApS, Frederiksberg (DK)
Filed on Jan. 3, 2025, as Appl. No. 19/009,660.
Claims priority of application No. 24150289.7 (EP), filed on Jan. 4, 2024.
Prior Publication US 2025/0223294 A1, Jul. 10, 2025
Int. Cl. C07D 487/04 (2006.01); A61K 31/5377 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01); C07D 471/04 (2006.01)
CPC C07D 487/04 (2013.01) [A61K 31/5377 (2013.01); A61P 25/00 (2018.01); A61P 25/28 (2018.01); C07D 471/04 (2013.01)] 23 Claims
 
1. A compound selected from:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.